Overview

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

Status:
RECRUITING
Trial end date:
2027-08-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to learn if DT-101 can treat depression in adults. The effect of DT-101 will be compared to placebo. Subjects will attend the clinic every couple of weeks complete general health checks and complete questionnaires.
Phase:
PHASE2
Details
Lead Sponsor:
Draig Therapeutics Ltd